114 related articles for article (PubMed ID: 33125707)
1. Vitamin E attenuates the development of bleomycin-induced skin fibrosis in mice.
Ruan L; Yang P; Chen SP; Wu C; Zhu QX
Australas J Dermatol; 2021 May; 62(2):e298-e300. PubMed ID: 33125707
[No Abstract] [Full Text] [Related]
2. Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis.
Desallais L; Avouac J; Fréchet M; Elhai M; Ratsimandresy R; Montes M; Mouhsine H; Do H; Zagury JF; Allanore Y
Arthritis Res Ther; 2014 Jul; 16(4):R157. PubMed ID: 25059342
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous toxicity of bleomycin therapy.
Cohen IS; Mosher MB; O'Keefe EJ; Klaus SN; De Conti RC
Arch Dermatol; 1973 Apr; 107(4):553-5. PubMed ID: 4121404
[No Abstract] [Full Text] [Related]
4. Correspondence re: M. T. Goodman et al., effects of beta-carotene and alpha-tocopherol on bleomycin-induced chromosomal damage. Cancer Epidemiol. Biomark. Prev., 7: 113-117, 1998.
King TM; Hursting S; Contois J; Wu X; Spitz MR; Hsu TC
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):729. PubMed ID: 9718227
[No Abstract] [Full Text] [Related]
5. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin-17 levels in bleomycin-induced dermal fibrosis.
Karatas A; Celik C; Oz B; Akar ZA; Etem EO; Dagli AF; Koca SS
Int J Rheum Dis; 2021 Jun; 24(6):795-802. PubMed ID: 33835703
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin-induced epithelial-mesenchymal transition in sclerotic skin of mice: possible role of oxidative stress in the pathogenesis.
Zhou CF; Zhou DC; Zhang JX; Wang F; Cha WS; Wu CH; Zhu QX
Toxicol Appl Pharmacol; 2014 Jun; 277(3):250-8. PubMed ID: 24726524
[TBL] [Abstract][Full Text] [Related]
7. Animal model of sclerotic skin induced by bleomycin: a clue to the pathogenesis of and therapy for scleroderma?
Yamamoto T
Clin Immunol; 2002 Mar; 102(3):209-16. PubMed ID: 11890707
[No Abstract] [Full Text] [Related]
8. Lysyl oxidase promotes bleomycin-induced lung fibrosis through modulating inflammation.
Cheng T; Liu Q; Zhang R; Zhang Y; Chen J; Yu R; Ge G
J Mol Cell Biol; 2014 Dec; 6(6):506-15. PubMed ID: 25348956
[TBL] [Abstract][Full Text] [Related]
9. T cell independence of bleomycin-induced pulmonary fibrosis.
Helene M; Lake-Bullock V; Zhu J; Hao H; Cohen DA; Kaplan AM
J Leukoc Biol; 1999 Feb; 65(2):187-95. PubMed ID: 10088601
[TBL] [Abstract][Full Text] [Related]
10. Exosomes derived from miR-16-5p-overexpressing keratinocytes attenuates bleomycin-induced skin fibrosis.
Bo Y; Liu B; Yang L; Zhang L; Yan Y
Biochem Biophys Res Commun; 2021 Jul; 561():113-119. PubMed ID: 34022711
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin and the skin.
Yamamoto T
Br J Dermatol; 2006 Nov; 155(5):869-75. PubMed ID: 17034512
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive assessment of bleomycin-induced lung injury and the effects of short-term glucocorticosteroid treatment in rats using MRI.
Babin AL; Cannet C; Gérard C; Wyss D; Page CP; Beckmann N
J Magn Reson Imaging; 2011 Mar; 33(3):603-14. PubMed ID: 21563244
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma.
Zhou CF; Yu JF; Zhang JX; Jiang T; Xu SH; Yu QY; Zhu QX
Clin Exp Dermatol; 2013 Jun; 38(4):403-9. PubMed ID: 23517443
[TBL] [Abstract][Full Text] [Related]
14. Amphiregulin attenuates bleomycin-induced pneumopathy in mice.
Fukumoto J; Harada C; Kawaguchi T; Suetsugu S; Maeyama T; Inoshima I; Hamada N; Kuwano K; Nakanishi Y
Am J Physiol Lung Cell Mol Physiol; 2010 Feb; 298(2):L131-8. PubMed ID: 19915156
[TBL] [Abstract][Full Text] [Related]
15. Attenuating Effects of Nortrachelogenin on IL-4 and IL-13 Induced Alternative Macrophage Activation and on Bleomycin-Induced Dermal Fibrosis.
Pemmari A; Leppänen T; Paukkeri EL; Scotece M; Hämäläinen M; Moilanen E
J Agric Food Chem; 2018 Dec; 66(51):13405-13413. PubMed ID: 30458613
[TBL] [Abstract][Full Text] [Related]
16. Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice.
Chilakapati SR; Serasanambati M; Manikonda PK; Chilakapati DR; Watson RR
Can J Physiol Pharmacol; 2014 Aug; 92(8):631-9. PubMed ID: 24933624
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the mechanism of bleomycin-induced cutaneous fibrosis in mice.
Ichihashi M; Shinkai H; Takei M; Sano S
J Antibiot (Tokyo); 1973 Apr; 26(4):238-42. PubMed ID: 4131332
[No Abstract] [Full Text] [Related]
18. [Effect of water-soluble C(60) fullerenes on pulmonary fibrosis induced by bleomycin in mice].
Dong R; Liu M; Huang XX; Liu Z; Jiang DY; Xiao HJ; Dai HP
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(22):1740-1744. PubMed ID: 28606286
[No Abstract] [Full Text] [Related]
19. [The experimental study of bleomycin-induced pulmonary fibrosis in the guinea pigs].
Liu XH
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Feb; 9(1):28-9, 62-3. PubMed ID: 2427290
[No Abstract] [Full Text] [Related]
20. The anti-fibrotic agent SMP-534 attenuates bleomycin-induced pulmonary fibrosis in hamsters.
Tsujimura T; Ono-Kishino M; Nagamine J; Sugaru E; Tokunaga T; Kitoh M; Nagata R; Nakagawa T; Taiji M
Biomed Res; 2009 Jun; 30(3):177-82. PubMed ID: 19574719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
